Testing effectiveness (Phase 2)Ended earlyNCT04042714What this trial is testingTAS-102 in Extrapulmonary Neuroendocrine CarcinomaWho this might be right forHigh-grade Extra Pulmonary Neuroendocrine Cancer Baylor Research Institute 14